PDT Partners’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-101,609
Closed -$488K 629
2025
Q3
$488K Sell
101,609
-124,231
-55% -$790K 0.03% 454
2025
Q2
$2.06M Buy
+225,840
New +$1.66M 0.12% 290
2024
Q3
Sell
-42,908
Closed -$579K 797
2024
Q2
$579K Sell
42,908
-16,262
-27% -$333K 0.05% 438
2024
Q1
$1.64M Buy
+59,170
New +$1.31M 0.16% 231
2022
Q4
Sell
-14,613
Closed -$352K 818
2022
Q3
$352K Buy
+14,613
New +$450K 0.05% 536
2015
Q2
Sell
-45,643
Closed -$1.54M 1553
2015
Q1
$1.54M Buy
45,643
+1,104
+2% +$38.5K 0.04% 550
2014
Q4
$1.56M Buy
+44,539
New +$1.5M 0.15% 149
2014
Q3
Sell
-53,544
Closed -$1.82M 1513
2014
Q2
$1.82M Buy
53,544
+20,715
+63% +$710K 0.05% 468
2014
Q1
$1.15M Buy
+32,829
New +$1.16M 0.03% 635
2013
Q4
Sell
-19,547
Closed -$676K 1015
2013
Q3
$676K Sell
19,547
-48,248
-71% -$1.69M 0.02% 928
2013
Q2
$2.29M Buy
+67,795
New +$2.25M 0.06% 486

Other funds holding ACH

PDT Partners's ACH Position: Q4 2025 in Review

PDT Partners sold out of Accendra Health (ACH) in Q4 2025, closing a stake of 101,609 shares — an estimated $488K sold.

PDT Partners first reported a position in ACH in Q2 2013 and held it in 11 quarters. The position peaked at $2.29M in Q2 2013. 168 funds tracked by Wall St. Rank hold ACH as of Q4 2025.

  • PDT Partners reported no remaining Accendra Health position as of Q4 2025 after selling out during the quarter.
  • PDT Partners sold 101,609 Accendra Health shares in Q4 2025, an estimated $488K.
  • PDT Partners first reported a position in Accendra Health in Q2 2013 and held it in 11 quarters.
  • PDT Partners's Accendra Health position peaked at $2.29M in Q2 2013.
  • 168 funds tracked by Wall St. Rank held Accendra Health as of Q4 2025.

Based on PDT Partners's 13F filing for Q4 2025, filed 17 Feb 2026.